KMDS
E-submission
Search
- Page Path
- HOME > Search
Viewpoint
- Mask on, Mask off: Subclinical Parkinson’s Disease Unveiled by COVID-19
- Milan Beckers, Bastiaan R Bloem, Rick C Helmich
- J Mov Disord. 2023;16(1):55-58. Published online November 10, 2022
- DOI: https://doi.org/10.14802/jmd.22067
- 7,549 View
- 123 Download
- 4 Web of Science
- 4 Crossref
-
PDF -
Citations
Citations to this article as recorded by
- Multi-omics integration identifies MT2A as a biomarker and a candidate host target linking zinc dysregulation to COVID-19 mortality
Zhonghua Li, Siqi Hua, Shuangshuang Song, Yixiang Luo, Wei Qian, Lina Liu, Jiahuang Li, Bo Zhu
Targetome.2026;[Epub] CrossRef - Shades of grey: The continuum of therapies for Parkinson's disease along the spectrum of credibility
Araceli Alonso-Canovas, Olaf M Dekkers, Bastiaan R. Bloem
Journal of Parkinson’s Disease.2025; 15(7): 1147. CrossRef - The Last Straw: How Stress Can Unmask Parkinson’s Disease
Anouk van der Heide, Claudia Trenkwalder, Bastiaan R. Bloem, Rick C. Helmich
Journal of Parkinson’s Disease.2024; 14(4): 889. CrossRef - SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
Iro Boura, Mubasher A. Qamar, Francesco Daddoveri, Valentina Leta, Karolina Poplawska-Domaszewicz, Cristian Falup-Pecurariu, K. Ray Chaudhuri
Biomedicines.2023; 11(9): 2524. CrossRef
- Multi-omics integration identifies MT2A as a biomarker and a candidate host target linking zinc dysregulation to COVID-19 mortality
First
Prev
